SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2br4'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WOP_A_FFOA2887_1 (AMINOMETHYLTRANSFERA SE)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	3 / 3	ASP A 187 GLU A 87 ARG A 121	MG A 300 (-3.3A) SAM A 301 (-3.0A) SAM A 301 (-3.1A)	0.88A	1wopA-2br4A: undetectable	1wopA-2br4A: 19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	5 / 12	LEU A 88 LEU A 96 PHE A 145 GLY A 137 LEU A 119	None	1.07A	2aylA-2br4A: undetectable	2aylA-2br4A: 17.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_A_SAMA301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	10 / 12	GLU A 87 GLY A 89 TYR A 91 SER A 95 ARG A 117 ARG A 121 ASP A 138 CYH A 139 ALA A 161 ALA A 163	SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-4.3A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.7A) SAM A 301 (-2.9A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.78A	2bm9A-2br4A: 34.4	2bm9A-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_A_SAMA301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	11 / 12	LEU A 18 LEU A 64 GLU A 87 GLY A 89 TYR A 91 SER A 95 ARG A 121 ASP A 138 CYH A 139 ALA A 161 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-4.3A) SAM A 301 (-3.0A) SAM A 301 (-3.1A) SAM A 301 (-3.7A) SAM A 301 (-2.9A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.65A	2bm9A-2br4A: 34.4	2bm9A-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_B_SAMB301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	11 / 12	LEU A 18 LEU A 64 GLU A 87 GLY A 89 SER A 95 ASP A 116 ARG A 117 ARG A 121 ASP A 138 CYH A 139 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-3.0A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.7A) SAM A 301 (-2.9A) SAM A 301 ( 3.7A)	0.77A	2bm9B-2br4A: 33.8	2bm9B-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_C_SAMC301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	11 / 12	LEU A 18 LEU A 64 LYS A 65 GLU A 87 GLY A 89 TYR A 91 ASN A 92 ARG A 121 CYH A 139 ALA A 161 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-2.6A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-4.3A) None SAM A 301 (-3.1A) SAM A 301 (-2.9A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.50A	2bm9C-2br4A: 34.5	2bm9C-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_C_SAMC301_1 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	4 / 4	SER A 95 ASP A 116 ARG A 117 ASP A 138	SAM A 301 (-3.0A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.7A)	0.47A	2bm9C-2br4A: 34.5	2bm9C-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_D_SAMD301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	12 / 12	LEU A 18 LEU A 64 LYS A 65 GLU A 87 GLY A 89 TYR A 91 SER A 95 ARG A 117 ARG A 121 CYH A 139 ALA A 161 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-2.6A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-4.3A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-2.9A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.53A	2bm9D-2br4A: 34.2	2bm9D-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_E_SAME301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	10 / 12	LEU A 18 LEU A 64 GLU A 87 GLY A 89 ASP A 116 ARG A 117 ARG A 121 ASP A 138 ALA A 161 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.7A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.45A	2bm9E-2br4A: 34.4	2bm9E-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_E_SAME301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	10 / 12	LEU A 18 LEU A 64 GLU A 87 GLY A 89 ASP A 116 ARG A 117 ASP A 138 CYH A 139 ALA A 161 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.7A) SAM A 301 (-2.9A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.57A	2bm9E-2br4A: 34.4	2bm9E-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_F_SAMF301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	6 / 12	ASP A 116 ARG A 117 CYH A 139 ALA A 161 HIS A 162 ALA A 163	SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-2.9A) SAM A 301 (-3.6A) MG A 300 ( 4.4A) SAM A 301 ( 3.7A)	0.97A	2bm9F-2br4A: 32.9	2bm9F-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_F_SAMF301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	9 / 12	GLY A 17 LEU A 18 LEU A 64 GLY A 89 ASP A 116 ALA A 161 HIS A 162 ALA A 163 ASP A 187	P4C A 500 (-4.0A) SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-3.3A) SAM A 301 (-3.0A) SAM A 301 (-3.6A) MG A 300 ( 4.4A) SAM A 301 ( 3.7A) MG A 300 (-3.3A)	0.64A	2bm9F-2br4A: 32.9	2bm9F-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_F_SAMF301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	8 / 12	GLY A 17 LEU A 64 ASP A 116 CYH A 139 ALA A 161 HIS A 162 ALA A 163 ASP A 187	P4C A 500 (-4.0A) SAM A 301 (-4.2A) SAM A 301 (-3.0A) SAM A 301 (-2.9A) SAM A 301 (-3.6A) MG A 300 ( 4.4A) SAM A 301 ( 3.7A) MG A 300 (-3.3A)	0.78A	2bm9F-2br4A: 32.9	2bm9F-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_F_SAMF301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	6 / 12	GLY A 89 ASP A 116 ARG A 117 ALA A 161 HIS A 162 ALA A 163	SAM A 301 (-3.3A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.6A) MG A 300 ( 4.4A) SAM A 301 ( 3.7A)	0.79A	2bm9F-2br4A: 32.9	2bm9F-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BM9_F_SAMF301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	6 / 12	LEU A 64 GLY A 89 ASP A 116 ARG A 117 ALA A 161 HIS A 162	SAM A 301 (-4.2A) SAM A 301 (-3.3A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.6A) MG A 300 ( 4.4A)	1.21A	2bm9F-2br4A: 32.9	2bm9F-2br4A: 99.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_A_SAMA301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	12 / 12	LEU A 18 LEU A 64 GLU A 87 GLY A 89 TYR A 91 SER A 95 ARG A 117 ARG A 121 CYH A 139 ASP A 160 ALA A 161 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-4.3A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-2.9A) MG A 300 ( 3.6A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.03A	2br4A-2br4A: 38.4	2br4A-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_A_SAMA301_1 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	3 / 3	LYS A 65 ASP A 116 ASP A 138	SAM A 301 (-2.6A) SAM A 301 (-3.0A) SAM A 301 (-3.7A)	0.04A	2br4A-2br4A: 38.4	2br4A-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_B_SAMB301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	12 / 12	LEU A 64 LYS A 65 GLU A 87 GLY A 89 TYR A 91 ASN A 92 ARG A 117 ARG A 121 CYH A 139 ASP A 160 ALA A 161 ALA A 163	SAM A 301 (-4.2A) SAM A 301 (-2.6A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-4.3A) None SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-2.9A) MG A 300 ( 3.6A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.66A	2br4B-2br4A: 35.3	2br4B-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_B_SAMB301_1 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	4 / 4	LEU A 18 SER A 95 ASP A 116 ASP A 138	SAM A 301 ( 4.4A) SAM A 301 (-3.0A) SAM A 301 (-3.0A) SAM A 301 (-3.7A)	0.24A	2br4B-2br4A: 35.3	2br4B-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_C_SAMC301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	12 / 12	LEU A 18 LEU A 64 GLY A 89 TYR A 91 ARG A 117 ARG A 121 ASP A 138 CYH A 139 SER A 140 ASP A 160 ALA A 161 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-3.3A) SAM A 301 (-4.3A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.7A) SAM A 301 (-2.9A) None MG A 300 ( 3.6A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.51A	2br4C-2br4A: 35.7	2br4C-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_C_SAMC301_1 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	4 / 4	LYS A 65 GLU A 87 SER A 95 ASP A 116	SAM A 301 (-2.6A) SAM A 301 (-3.0A) SAM A 301 (-3.0A) SAM A 301 (-3.0A)	0.19A	2br4C-2br4A: 35.7	2br4C-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_D_SAMD301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	12 / 12	LEU A 18 LEU A 64 GLU A 87 GLY A 89 TYR A 91 SER A 95 ASP A 116 ARG A 117 ARG A 121 CYH A 139 ALA A 161 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-4.3A) SAM A 301 (-3.0A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-2.9A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.34A	2br4D-2br4A: 34.9	2br4D-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_D_SAMD301_1 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	3 / 3	LYS A 65 ASP A 138 ASP A 160	SAM A 301 (-2.6A) SAM A 301 (-3.7A) MG A 300 ( 3.6A)	0.19A	2br4D-2br4A: 34.9	2br4D-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_E_SAME301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	12 / 12	LEU A 18 LEU A 64 LYS A 65 GLU A 87 GLY A 89 TYR A 91 ARG A 117 ARG A 121 ASP A 138 ASP A 160 ALA A 161 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-2.6A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-4.3A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.7A) MG A 300 ( 3.6A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.30A	2br4E-2br4A: 35.2	2br4E-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_E_SAME301_1 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	3 / 3	SER A 95 ASP A 116 CYH A 139	SAM A 301 (-3.0A) SAM A 301 (-3.0A) SAM A 301 (-2.9A)	0.40A	2br4E-2br4A: 35.2	2br4E-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_F_SAMF301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	12 / 12	LEU A 18 LEU A 64 GLU A 87 GLY A 89 TYR A 91 SER A 95 ARG A 117 ARG A 121 ASP A 138 ASP A 160 ALA A 161 ALA A 163	SAM A 301 ( 4.4A) SAM A 301 (-4.2A) SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-4.3A) SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.1A) SAM A 301 (-3.7A) MG A 300 ( 3.6A) SAM A 301 (-3.6A) SAM A 301 ( 3.7A)	0.49A	2br4F-2br4A: 34.9	2br4F-2br4A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2BR4_F_SAMF301_1 (CEPHALOSPORIN HYDROXYLASE CMCI)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	3 / 3	LYS A 65 ASP A 116 CYH A 139	SAM A 301 (-2.6A) SAM A 301 (-3.0A) SAM A 301 (-2.9A)	0.33A	2br4F-2br4A: 34.9	2br4F-2br4A: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VAV_L_CSCL1383_2 (ACETYL-COA--DEACETYL CEPHALOSPORIN C ACETYLTRANSFERASE)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	4 / 4	THR A 103 LEU A 102 MET A 106 MET A 129	None	1.35A	2vavL-2br4A: 1.9	2vavL-2br4A: 20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A7E_A_SAMA216_1 (CATECHOL O-METHYLTRANSFERASE)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	4 / 6	GLY A 89 SER A 95 ILE A 115 ASP A 160	SAM A 301 (-3.3A) SAM A 301 (-3.0A) None MG A 300 ( 3.6A)	0.78A	3a7eA-2br4A: 14.5	3a7eA-2br4A: 22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GP0_A_NILA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	4 / 7	ARG A 81 VAL A 228 MET A 169 ILE A 184	None	0.94A	3gp0A-2br4A: undetectable	3gp0A-2br4A: 21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LM8_C_VIBC223_1 (THIAMINE PYROPHOSPHOKINASE)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	4 / 8	ASP A 116 LEU A 96 CYH A 122 ASN A 92	SAM A 301 (-3.0A) None None None	1.03A	3lm8A-2br4A: undetectable 3lm8C-2br4A: undetectable	3lm8A-2br4A: 18.80 3lm8C-2br4A: 18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B53_B_ACTB1445_0 (IG GAMMA-4 CHAIN C REGION)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	3 / 3	GLU A 87 GLY A 89 SER A 95	SAM A 301 (-3.0A) SAM A 301 (-3.3A) SAM A 301 (-3.0A)	0.59A	4b53B-2br4A: undetectable	4b53B-2br4A: 17.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YMG_B_SAMB1001_0 (PUTATIVE SAM-DEPENDENT O-METHYLTRANFERASE)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	5 / 12	GLY A 89 TYR A 91 SER A 95 ASP A 160 ALA A 161	SAM A 301 (-3.3A) SAM A 301 (-4.3A) SAM A 301 (-3.0A) MG A 300 ( 3.6A) SAM A 301 (-3.6A)	0.77A	4ymgB-2br4A: 13.4	4ymgB-2br4A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ERG_B_SAMB401_0 (TRNA (ADENINE(58)-N(1))-M ETHYLTRANSFERASE CATALYTIC SUBUNIT TRM61)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	5 / 12	GLN A 111 ILE A 85 VAL A 86 PHE A 157 ARG A 83	None	1.07A	5ergB-2br4A: 9.4	5ergB-2br4A: 20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NFJ_B_SAMB501_0 (MITOCHONDRIAL RIBONUCLEASE P PROTEIN 1)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	5 / 12	ILE A 113 GLY A 114 ASP A 160 LEU A 176 LEU A 177	None None MG A 300 ( 3.6A) None None	1.24A	5nfjB-2br4A: undetectable	5nfjB-2br4A: 21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NFJ_C_SAMC501_0 (MITOCHONDRIAL RIBONUCLEASE P PROTEIN 1)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	5 / 12	ILE A 113 GLY A 114 ASP A 160 LEU A 176 LEU A 177	None None MG A 300 ( 3.6A) None None	1.24A	5nfjC-2br4A: undetectable	5nfjC-2br4A: 21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UHC_C_RFPC1201_2 (DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	3 / 3	PHE A 183 ASP A 181 LEU A 216	None	0.75A	5uhcC-2br4A: undetectable	5uhcC-2br4A: 10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UXC_A_ZITA307_1 (PREDICTED AMINOGLYCOSIDE PHOSPHOTRANSFERASE)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	4 / 5	ASP A 214 PRO A 154 GLU A 178 ARG A 231	None	1.32A	5uxcA-2br4A: undetectable	5uxcA-2br4A: 23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZW4_A_SAMA302_1 (PUTATIVE O-METHYLTRANSFERASE YRRM)	2br4	CEPHALOSPORIN HYDROXYLASE CMCI (Streptomyces clavuligerus)	4 / 6	SER A 95 ARG A 117 ASP A 138 ASP A 160	SAM A 301 (-3.0A) SAM A 301 (-3.7A) SAM A 301 (-3.7A) MG A 300 ( 3.6A)	1.12A	5zw4A-2br4A: 14.4	5zw4A-2br4A: 23.33

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1WOP_A_FFOA2887_1","AMINOMETHYLTRANSFERASE","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",3,"ASP A 187;GLU A  87;ARG A 121"," MG A 300 (-3.3A);SAM A 301 (-3.0A);SAM A 301 (-3.1A)","0.88A","1wopA-2br4A:undetectable","1wopA-2br4A:19.20"],["2AYL_A_FLPA1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",5,"LEU A  88;LEU A  96;PHE A 145;GLY A 137;LEU A 119","None","1.07A","2aylA-2br4A:undetectable","2aylA-2br4A:17.18"],["2BM9_A_SAMA301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",10,"GLU A  87;GLY A  89;TYR A  91;SER A  95;ARG A 117;ARG A 121;ASP A 138;CYH A 139;ALA A 161;ALA A 163","SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-4.3A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.7A);SAM A 301 (-2.9A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.78A","2bm9A-2br4A:34.4","2bm9A-2br4A:99.15"],["2BM9_A_SAMA301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",11,"LEU A  18;LEU A  64;GLU A  87;GLY A  89;TYR A  91;SER A  95;ARG A 121;ASP A 138;CYH A 139;ALA A 161;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-4.3A);SAM A 301 (-3.0A);SAM A 301 (-3.1A);SAM A 301 (-3.7A);SAM A 301 (-2.9A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.65A","2bm9A-2br4A:34.4","2bm9A-2br4A:99.15"],["2BM9_B_SAMB301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",11,"LEU A  18;LEU A  64;GLU A  87;GLY A  89;SER A  95;ASP A 116;ARG A 117;ARG A 121;ASP A 138;CYH A 139;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-3.0A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.7A);SAM A 301 (-2.9A);SAM A 301 ( 3.7A)","0.77A","2bm9B-2br4A:33.8","2bm9B-2br4A:99.15"],["2BM9_C_SAMC301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",11,"LEU A  18;LEU A  64;LYS A  65;GLU A  87;GLY A  89;TYR A  91;ASN A  92;ARG A 121;CYH A 139;ALA A 161;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-2.6A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-4.3A);None;SAM A 301 (-3.1A);SAM A 301 (-2.9A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.50A","2bm9C-2br4A:34.5","2bm9C-2br4A:99.15"],["2BM9_C_SAMC301_1","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",4,"SER A  95;ASP A 116;ARG A 117;ASP A 138","SAM A 301 (-3.0A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.7A)","0.47A","2bm9C-2br4A:34.5","2bm9C-2br4A:99.15"],["2BM9_D_SAMD301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",12,"LEU A  18;LEU A  64;LYS A  65;GLU A  87;GLY A  89;TYR A  91;SER A  95;ARG A 117;ARG A 121;CYH A 139;ALA A 161;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-2.6A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-4.3A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-2.9A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.53A","2bm9D-2br4A:34.2","2bm9D-2br4A:99.15"],["2BM9_E_SAME301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",10,"LEU A  18;LEU A  64;GLU A  87;GLY A  89;ASP A 116;ARG A 117;ARG A 121;ASP A 138;ALA A 161;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.7A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.45A","2bm9E-2br4A:34.4","2bm9E-2br4A:99.15"],["2BM9_E_SAME301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",10,"LEU A  18;LEU A  64;GLU A  87;GLY A  89;ASP A 116;ARG A 117;ASP A 138;CYH A 139;ALA A 161;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.7A);SAM A 301 (-2.9A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.57A","2bm9E-2br4A:34.4","2bm9E-2br4A:99.15"],["2BM9_F_SAMF301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",6,"ASP A 116;ARG A 117;CYH A 139;ALA A 161;HIS A 162;ALA A 163","SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-2.9A);SAM A 301 (-3.6A); MG A 300 ( 4.4A);SAM A 301 ( 3.7A)","0.97A","2bm9F-2br4A:32.9","2bm9F-2br4A:99.15"],["2BM9_F_SAMF301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",9,"GLY A  17;LEU A  18;LEU A  64;GLY A  89;ASP A 116;ALA A 161;HIS A 162;ALA A 163;ASP A 187","P4C A 500 (-4.0A);SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-3.3A);SAM A 301 (-3.0A);SAM A 301 (-3.6A); MG A 300 ( 4.4A);SAM A 301 ( 3.7A); MG A 300 (-3.3A)","0.64A","2bm9F-2br4A:32.9","2bm9F-2br4A:99.15"],["2BM9_F_SAMF301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",8,"GLY A  17;LEU A  64;ASP A 116;CYH A 139;ALA A 161;HIS A 162;ALA A 163;ASP A 187","P4C A 500 (-4.0A);SAM A 301 (-4.2A);SAM A 301 (-3.0A);SAM A 301 (-2.9A);SAM A 301 (-3.6A); MG A 300 ( 4.4A);SAM A 301 ( 3.7A); MG A 300 (-3.3A)","0.78A","2bm9F-2br4A:32.9","2bm9F-2br4A:99.15"],["2BM9_F_SAMF301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",6,"GLY A  89;ASP A 116;ARG A 117;ALA A 161;HIS A 162;ALA A 163","SAM A 301 (-3.3A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.6A); MG A 300 ( 4.4A);SAM A 301 ( 3.7A)","0.79A","2bm9F-2br4A:32.9","2bm9F-2br4A:99.15"],["2BM9_F_SAMF301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",6,"LEU A  64;GLY A  89;ASP A 116;ARG A 117;ALA A 161;HIS A 162","SAM A 301 (-4.2A);SAM A 301 (-3.3A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.6A); MG A 300 ( 4.4A)","1.21A","2bm9F-2br4A:32.9","2bm9F-2br4A:99.15"],["2BR4_A_SAMA301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",12,"LEU A  18;LEU A  64;GLU A  87;GLY A  89;TYR A  91;SER A  95;ARG A 117;ARG A 121;CYH A 139;ASP A 160;ALA A 161;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-4.3A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-2.9A); MG A 300 ( 3.6A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.03A","2br4A-2br4A:38.4","2br4A-2br4A:100.00"],["2BR4_A_SAMA301_1","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",3,"LYS A  65;ASP A 116;ASP A 138","SAM A 301 (-2.6A);SAM A 301 (-3.0A);SAM A 301 (-3.7A)","0.04A","2br4A-2br4A:38.4","2br4A-2br4A:100.00"],["2BR4_B_SAMB301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",12,"LEU A  64;LYS A  65;GLU A  87;GLY A  89;TYR A  91;ASN A  92;ARG A 117;ARG A 121;CYH A 139;ASP A 160;ALA A 161;ALA A 163","SAM A 301 (-4.2A);SAM A 301 (-2.6A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-4.3A);None;SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-2.9A); MG A 300 ( 3.6A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.66A","2br4B-2br4A:35.3","2br4B-2br4A:100.00"],["2BR4_B_SAMB301_1","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",4,"LEU A  18;SER A  95;ASP A 116;ASP A 138","SAM A 301 ( 4.4A);SAM A 301 (-3.0A);SAM A 301 (-3.0A);SAM A 301 (-3.7A)","0.24A","2br4B-2br4A:35.3","2br4B-2br4A:100.00"],["2BR4_C_SAMC301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",12,"LEU A  18;LEU A  64;GLY A  89;TYR A  91;ARG A 117;ARG A 121;ASP A 138;CYH A 139;SER A 140;ASP A 160;ALA A 161;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-3.3A);SAM A 301 (-4.3A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.7A);SAM A 301 (-2.9A);None; MG A 300 ( 3.6A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.51A","2br4C-2br4A:35.7","2br4C-2br4A:100.00"],["2BR4_C_SAMC301_1","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",4,"LYS A  65;GLU A  87;SER A  95;ASP A 116","SAM A 301 (-2.6A);SAM A 301 (-3.0A);SAM A 301 (-3.0A);SAM A 301 (-3.0A)","0.19A","2br4C-2br4A:35.7","2br4C-2br4A:100.00"],["2BR4_D_SAMD301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",12,"LEU A  18;LEU A  64;GLU A  87;GLY A  89;TYR A  91;SER A  95;ASP A 116;ARG A 117;ARG A 121;CYH A 139;ALA A 161;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-4.3A);SAM A 301 (-3.0A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-2.9A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.34A","2br4D-2br4A:34.9","2br4D-2br4A:100.00"],["2BR4_D_SAMD301_1","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",3,"LYS A  65;ASP A 138;ASP A 160","SAM A 301 (-2.6A);SAM A 301 (-3.7A); MG A 300 ( 3.6A)","0.19A","2br4D-2br4A:34.9","2br4D-2br4A:100.00"],["2BR4_E_SAME301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",12,"LEU A  18;LEU A  64;LYS A  65;GLU A  87;GLY A  89;TYR A  91;ARG A 117;ARG A 121;ASP A 138;ASP A 160;ALA A 161;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-2.6A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-4.3A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.7A); MG A 300 ( 3.6A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.30A","2br4E-2br4A:35.2","2br4E-2br4A:100.00"],["2BR4_E_SAME301_1","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",3,"SER A  95;ASP A 116;CYH A 139","SAM A 301 (-3.0A);SAM A 301 (-3.0A);SAM A 301 (-2.9A)","0.40A","2br4E-2br4A:35.2","2br4E-2br4A:100.00"],["2BR4_F_SAMF301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",12,"LEU A  18;LEU A  64;GLU A  87;GLY A  89;TYR A  91;SER A  95;ARG A 117;ARG A 121;ASP A 138;ASP A 160;ALA A 161;ALA A 163","SAM A 301 ( 4.4A);SAM A 301 (-4.2A);SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-4.3A);SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.1A);SAM A 301 (-3.7A); MG A 300 ( 3.6A);SAM A 301 (-3.6A);SAM A 301 ( 3.7A)","0.49A","2br4F-2br4A:34.9","2br4F-2br4A:100.00"],["2BR4_F_SAMF301_1","CEPHALOSPORIN HYDROXYLASE CMCI","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",3,"LYS A  65;ASP A 116;CYH A 139","SAM A 301 (-2.6A);SAM A 301 (-3.0A);SAM A 301 (-2.9A)","0.33A","2br4F-2br4A:34.9","2br4F-2br4A:100.00"],["2VAV_L_CSCL1383_2","ACETYL-COA--DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",4,"THR A 103;LEU A 102;MET A 106;MET A 129","None","1.35A","2vavL-2br4A:1.9","2vavL-2br4A:20.22"],["3A7E_A_SAMA216_1","CATECHOL O-METHYLTRANSFERASE","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",4,"GLY A  89;SER A  95;ILE A 115;ASP A 160","SAM A 301 (-3.3A);SAM A 301 (-3.0A);None; MG A 300 ( 3.6A)","0.78A","3a7eA-2br4A:14.5","3a7eA-2br4A:22.09"],["3GP0_A_NILA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 11","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",4,"ARG A  81;VAL A 228;MET A 169;ILE A 184","None","0.94A","3gp0A-2br4A:undetectable","3gp0A-2br4A:21.91"],["3LM8_C_VIBC223_1","THIAMINE PYROPHOSPHOKINASE;THIAMINE PYROPHOSPHOKINASE","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",4,"ASP A 116;LEU A  96;CYH A 122;ASN A  92","SAM A 301 (-3.0A);None;None;None","1.03A","3lm8A-2br4A:undetectable;3lm8C-2br4A:undetectable","3lm8A-2br4A:18.80;3lm8C-2br4A:18.80"],["4B53_B_ACTB1445_0","IG GAMMA-4 CHAIN C REGION","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",3,"GLU A  87;GLY A  89;SER A  95","SAM A 301 (-3.0A);SAM A 301 (-3.3A);SAM A 301 (-3.0A)","0.59A","4b53B-2br4A:undetectable","4b53B-2br4A:17.23"],["4YMG_B_SAMB1001_0","PUTATIVE SAM-DEPENDENT O-METHYLTRANFERASE","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",5,"GLY A  89;TYR A  91;SER A  95;ASP A 160;ALA A 161","SAM A 301 (-3.3A);SAM A 301 (-4.3A);SAM A 301 (-3.0A); MG A 300 ( 3.6A);SAM A 301 (-3.6A)","0.77A","4ymgB-2br4A:13.4","4ymgB-2br4A:25.00"],["5ERG_B_SAMB401_0","TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE CATALYTIC SUBUNIT TRM61","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",5,"GLN A 111;ILE A  85;VAL A  86;PHE A 157;ARG A  83","None","1.07A","5ergB-2br4A:9.4","5ergB-2br4A:20.30"],["5NFJ_B_SAMB501_0","MITOCHONDRIAL RIBONUCLEASE P PROTEIN 1","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",5,"ILE A 113;GLY A 114;ASP A 160;LEU A 176;LEU A 177","None;None; MG A 300 ( 3.6A);None;None","1.24A","5nfjB-2br4A:undetectable","5nfjB-2br4A:21.26"],["5NFJ_C_SAMC501_0","MITOCHONDRIAL RIBONUCLEASE P PROTEIN 1","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",5,"ILE A 113;GLY A 114;ASP A 160;LEU A 176;LEU A 177","None;None; MG A 300 ( 3.6A);None;None","1.24A","5nfjC-2br4A:undetectable","5nfjC-2br4A:21.26"],["5UHC_C_RFPC1201_2","DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",3,"PHE A 183;ASP A 181;LEU A 216","None","0.75A","5uhcC-2br4A:undetectable","5uhcC-2br4A:10.94"],["5UXC_A_ZITA307_1","PREDICTED AMINOGLYCOSIDE PHOSPHOTRANSFERASE","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",4,"ASP A 214;PRO A 154;GLU A 178;ARG A 231","None","1.32A","5uxcA-2br4A:undetectable","5uxcA-2br4A:23.26"],["5ZW4_A_SAMA302_1","PUTATIVE O-METHYLTRANSFERASE YRRM","2br4","CEPHALOSPORIN HYDROXYLASE CMCI","Streptomyces clavuligerus",4,"SER A  95;ARG A 117;ASP A 138;ASP A 160","SAM A 301 (-3.0A);SAM A 301 (-3.7A);SAM A 301 (-3.7A); MG A 300 ( 3.6A)","1.12A","5zw4A-2br4A:14.4","5zw4A-2br4A:23.33"]]